KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Debt to Equity: 2009-2025

Historic Debt to Equity for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to $0.70.

  • Thermo Fisher Scientific's Debt to Equity fell 3.02% to $0.70 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.70, marking a year-over-year decrease of 3.02%. This contributed to the annual value of $0.63 for FY2024, which is 15.58% down from last year.
  • Thermo Fisher Scientific's Debt to Equity amounted to $0.70 in Q3 2025, which was up 0.26% from $0.70 recorded in Q2 2025.
  • Thermo Fisher Scientific's Debt to Equity's 5-year high stood at $0.85 during Q4 2021, with a 5-year trough of $0.51 in Q3 2021.
  • Its 3-year average for Debt to Equity is $0.74, with a median of $0.75 in 2024.
  • In the last 5 years, Thermo Fisher Scientific's Debt to Equity declined by 28.58% in 2021 and then spiked by 52.44% in 2022.
  • Quarterly analysis of 5 years shows Thermo Fisher Scientific's Debt to Equity stood at $0.85 in 2021, then fell by 8.23% to $0.78 in 2022, then decreased by 4.61% to $0.75 in 2023, then fell by 15.58% to $0.63 in 2024, then fell by 3.02% to $0.70 in 2025.
  • Its last three reported values are $0.70 in Q3 2025, $0.70 for Q2 2025, and $0.69 during Q1 2025.